On the contrary, several risk factors for cardiovascular diseases, including angiotensin II (Luo et al., 2019), inflammation (Shao et al., 2020), and aging (Luo et al., 2018), all lead to down-regulation of eNOS S1177 phosphorylation and consequently its enzymatic activity. This evidence concerns the gene NOS3 and cardiovascular disorder.